Annual Awards Recognize Innovative Companies and Projects Addressing the World’s Most Urgent Challenges
CHICAGO, IL [June 10, 2025] — Prenosis is proud to announce that Sepsis ImmunoScore™ has been named an honoree of Fast Company’s 2025 World Changing Ideas Awards. This annual recognition honors bold and transformative efforts that tackle the world’s most pressing issues—from fresh sustainability initiatives and cutting-edge AI developments to ambitious pursuits of social equity that are helping mold the world.
Recognized in the Technology Solutions category, Sepsis ImmunoScore is the first FDA-authorized AI diagnostic tool for sepsis. In 2024, Prenosis achieved several major milestones including FDA De Novo authorization, a commercial distribution partnership with Roche Diagnostics, and recognition by TIME as a Best Invention of 2024.
This year’s awards, featured on fastcompany.com, showcase 50 winners across 12 categories and 50 additional winners across industries, for a total of 100 outstanding projects. A panel of Fast Company editors and reporters selected the winners from a pool of more than 1,500 entries and judged applications based on their impact, sustainability, design, creativity, scalability, and ability to improve society.
“We are honored to be recognized by Fast Company for our commitment to changing the paradigm of critical care,” said Bobby Reddy, Jr., PhD, CEO of Prenosis. “Sepsis ImmunoScore represents a fundamental shift toward precision medicine in acute care. This recognition validates our mission to develop AI-powered solutions that can save lives and make healthcare more equitable for patients worldwide. We believe our breakthrough technology has the potential to dramatically improve outcomes for millions of patients.”
Fast Company’s Summer 2025 issue (on newsstands June 17, 2025) will feature select award winners working on solutions such as a spinal cord stimulator for people who’ve been injured, modular bus shelters in Los Angeles, and AI to help eliminate counterfeit drugs.
“The World Changing Ideas Awards have always been about showcasing the art of the possible,” says Fast Company editor-in-chief Brendan Vaughan. “We’re proud to recognize the organizations and leaders that are making meaningful progress on the biggest issues of our time.”
ABOUT PRENOSIS, INC.
Prenosis Inc. is an artificial intelligence company pioneering precision medicine in acute care. We believe healthcare should be tailored to individual biology. Our data-driven approach to fast-moving biology in acute care is ushering in a new era of precision medicine. Powered by our Immunix™ precision medicine platform, we generate proprietary biological insights that drive development of precision products and enable real-time delivery of optimal therapy. With this, we created and validated Sepsis ImmunoScore, the first FDA-authorized AI tool for sepsis.
ABOUT FAST COMPANY
Fast Company is the only media brand fully dedicated to the vital intersection of business, innovation, and design, engaging the most influential leaders, companies, and thinkers on the future of business. Headquartered in New York City, Fast Company is published by Mansueto Ventures LLC, along with our sister publication Inc., and can be found online at www.fastcompany.com.